John Alexander Kelly - 31 Aug 2021 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role: Chief Financial Officer
Signature: /s/ John Alexander Kelly
Issuer symbol: DTIL
Transactions as of: 31 Aug 2021
Net transactions value: +$20,456
Form type: 4
Filing time: 07 Mar 2022, 15:08:30 UTC
Previous filing: 09 Jun 2021
Next filing: 21 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DTIL	Common Stock	Award	$10,659	+998	+6.3%	$10.68	16,798	31 Aug 2021	Direct
transaction	DTIL	Common Stock	Award	$9,798	+2,714	+16%	$3.61	19,512	28 Feb 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DTIL	Employee Stock Option (Right to Buy)	Award	$0	+243,274		$0.000000	243,274	03 Mar 2022	Common Stock	243,274	$4.08	Direct	F1
transaction	DTIL	Restricted Stock Units	Award	$0	+153,185		$0.000000	153,185	03 Mar 2022	Common Stock	153,185		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests as to 25% of the underlying shares on March 3, 2023 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
F2	The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.
F3	The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.